1. Erythema annulare centrifugum triggered by SARS‐CoV‐2 infection
- Author
-
María Teresa Fernández-Figueras, A Altemir, N Setó-Torrent, and M Iglesias-Sancho
- Subjects
Livedo ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,Erythema ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Dermatology ,Letters To The Editor ,Desquamation ,Erythematous plaque ,medicine ,Humans ,skin and connective tissue diseases ,Letter to the Editor ,integumentary system ,Erythema annulare centrifugum ,SARS-CoV-2 ,business.industry ,COVID-19 ,Skin Diseases, Genetic ,medicine.disease ,Infectious Diseases ,medicine.symptom ,business - Abstract
Erythema annulare centrifugum (EAC) is a reactive phenomenon of the skin that has been reported to occur in association with numerous conditions, including infections.1 It commonly presents with annular, erythematous plaques with a fine desquamation in the inner portion of the advancing edge.2 In the last year, a wide spectrum of cutaneous manifestations has been associated with SARS-CoV-2 infection, including acral areas of erythema with vesicles or pustules, other vesicular eruptions, urticarial lesions, maculopapular eruptions and livedo or necrosis.3,4.
- Published
- 2021